Ensituximab

Tax included
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer.
MedChemExpress 
HY-P99362

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Cancer-programmed cell death
CAS
1092658-06-4